BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 3293974)

  • 1. Impact of nursing interventions in obstetric and gynaecological surgery: A bibliometric and visual analysis.
    Xu H; Xiao L; Zhang H
    Asian J Surg; 2024 Jun; ():. PubMed ID: 38876880
    [No Abstract]   [Full Text] [Related]  

  • 2. The diagnostic role of urinary N-acetyl-beta-D-glucosaminidase (NAG) activity in the detection of renal tubular impairment.
    Skálová S
    Acta Medica (Hradec Kralove); 2005; 48(2):75-80. PubMed ID: 16259316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Urinary excretion of N-acetyl-beta-D-glucosaminidase and microglobulin 2 in type I diabetes mellitus].
    Sitjar de Togores Alvarez M; Muros de Fuentes M; León López C; García Nieto VM; López Mora E; Rial Rodríguez JM; Rodríguez Rodríguez I; Trujillo Armas R
    An Esp Pediatr; 1991 Mar; 34(3):225-9. PubMed ID: 2064152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of enzymuria and beta 2-microglobulinuria in patients receiving prophylactic cefotaxime in obstetric and gynaecological surgery.
    Ishikawa M; Yamashita K; Shimizu T
    Drugs; 1988; 35 Suppl 2():178-80. PubMed ID: 3293974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the antimicrobial prophylactic efficacy of cefotaxime and cephazolin in obstetric and gynaecological surgery. A randomised multicentre study.
    Periti P; Mazzei T; Orlandini F; Mini E
    Drugs; 1988; 35 Suppl 2():133-8. PubMed ID: 3396475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Administration of gallium nitrate by continuous infusion: lack of chronic nephrotoxicity confirmed by studies of enzymuria and beta 2-microglobulinuria.
    Leyland-Jones B; Bhalla RB; Farag F; Williams L; Coonley CJ; Warrell RP
    Cancer Treat Rep; 1983 Oct; 67(10):941-2. PubMed ID: 6354440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of methods of evaluating nephrotoxicity of cis-platinum.
    Jones BR; Bhalla RB; Mladek J; Kaleya RN; Gralla RJ; Alcock NW; Schwartz MK; Young CW; Reidenberg MM
    Clin Pharmacol Ther; 1980 Apr; 27(4):557-62. PubMed ID: 6987030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of methods for evaluating the nephrotoxicity of cisplatin].
    Suzumori K; Yasui Y; Suzumori K; Yagami Y; Seki T
    Gan To Kagaku Ryoho; 1988 Aug; 15(8):2251-6. PubMed ID: 3044273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal injury in patients with rheumatoid arthritis treated with gold.
    Merle LJ; Reidenberg MM; Camacho MT; Jones BR; Drayer DE
    Clin Pharmacol Ther; 1980 Aug; 28(2):216-22. PubMed ID: 6994990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative nephrotoxicity of gentamicin in nontoxic doses.
    Trollfors B; Alestig K; Krantz I; Norrby R
    J Infect Dis; 1980 Mar; 141(3):306-9. PubMed ID: 6988522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cefotaxime concentration in the bile and wall of the gallbladder.
    Soussy CJ; Deforges LP; Le Van Thoi J; Feghali W; Daval JR
    J Antimicrob Chemother; 1980 Sep; 6 Suppl A():125-30. PubMed ID: 6252143
    [No Abstract]   [Full Text] [Related]  

  • 12. Urinary excretion of N-acetyl-beta-D-glucosaminidase and alanine aminopeptidase in patients receiving amikacin or cis-platinum.
    Diener U; Knoll E; Langer B; Rautenstrauch H; Ratge D; Wisser H
    Clin Chim Acta; 1981 May; 112(2):149-57. PubMed ID: 6113066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nephrotoxicity of newer cephalosporins and aminoglycosides alone and in combination in a rat model.
    Barza M; Pinn V; Tanguay P; Murray T
    J Antimicrob Chemother; 1978 May; 4 Suppl A():59-68. PubMed ID: 659352
    [No Abstract]   [Full Text] [Related]  

  • 14. Quantitative distribution of lysosomal hydrolases in the rat nephron.
    Le Hir M; Dubach UC; Schmidt U
    Histochemistry; 1979 Sep; 63(2):245-51. PubMed ID: 500408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzymuria as a marker of renal injury and disease: studies of N-acetyl-beta-glucosaminidase in the general population and in patients with renal disease.
    Kunin CM; Chesney RW; Craig WA; England AC; DeAngelis C
    Pediatrics; 1978 Nov; 62(5):751-60. PubMed ID: 364392
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.